共 10 条
[1]
P53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Poller DN,Roberts EC,Bell JA,et al. Human Pathology . 1993
[2]
A prognostic index for ductal carcinoma in situ of the breast. Silverstein MJ,Lagios MD,Craig PH,et al. Cancer . 1996
[3]
The diagnosis and management of ductal carcinoma in-situ of the breast. Winchester DP,Jeske JM,Goldschmidt RA. CA A Cancer Journal for Clinicians . 2000
[4]
Ductal carcinoma in situ: implications for screening mammography. Feig SA. Radiologic Clinics of North America . 2000
[5]
Ductal carcinoma in situ of the breast:correlation between mammographic calcification and tumor subtype. Stomper PC,Connolly JL. American Journal of Roentgenology . 1992
[6]
Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Holland R,Hendriks JH,Verbeek AL,et al. The Lancet . 1990
[7]
Invasive lobular carcinoma of the breast :mammographic findings and extent of disease at diagnosis in 184 patients. Krecke KN,Gisvold JJ. American Journal of Roentgenology . 1993
[8]
Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation. Evans AJ,Pinder S,Ellis IO,et al. Radiology . 1994
[9]
Prognostic classification of breast ductal carcinoma-in-situ. Silverstein MJ,Poller DN,Waisman JR,et al. The Lancet . 1995
[10]
Invasive breast cancer. Andersson I. European Radiology . 2001